Howie and Harlan are joined by Yale School of Medicine neurologist Kevin Sheth to discuss how collaboration helps drive breakthroughs in brain health, including advances in detecting stroke and other neurological diseases earlier and more precisely. Harlan reflects on lessons from his family's recent experience navigating the healthcare system; Howie examines the expanding marketplace for GLP-1 weight-loss drugs and the challenges of ensuring safe and appropriate use.

Show notes:

The Family Perspective

Cleveland Clinic: Percutaneous Coronary Intervention

"What's the Difference Between a CCU and an ICU?"

Kevin Sheth

Alva Health

Mayo Clinic: Stroke

Video: Kevin Sheth at the Yale Innovation Summit

Sandra Saldana, PhD, MBA

"Buddy System"

NIH: Multiple Principal Investigators

"Assessing the Decade of the Brain"

"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease"

Kevin Sheth: "Burden of Ischemic and Hemorrhagic Stroke Across the US From 1990 to 2019"

Endovascular Thrombectomy (EVT)

Ischemic vs Hemorrhagic Stroke

"What is cognitive reserve?"

Cheaper Obesity Drugs

"Will Novo Nordisk's slashing of obesity drug prices save patients' money? It depends"

"Novo Nordisk to halve US list price of Wegovy from 2027"

"Walgreens Virtual Healthcare Adds Weight Management Services to Support Patients on Their Weight Loss Journey"

In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time.

Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings.

Email Howie and Harlan comments or questions.